Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors
NCT05599048Phase 2Recruiting
- Start
- Dec 2022
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyperpolarized 13C-pyruvate in solid tumor (advanced stage). Started Dec 2022; status: recruiting.
02
Drugs
hyperpolarized 13C-pyruvate
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT05599048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05599048.